Roles of SIRT1 in the Acute and Restorative Phases Following Induction of Inflammation
Overview
Affiliations
Endotoxin is a potent inducer of systemic inflammatory responses in human and rodents. Here, we show that in vivo endotoxin triggers a rapid and transient decline in ATP concentration in human peripheral blood leukocytes and murine peripheral blood leukocytes and liver, which is associated with a brief increase in expression of the autophagy indicator LC3-II. In both of these tissues, the ATP concentration reaches a nadir, and autophagy is induced between 2 and 4 h post-endotoxin infusion, and homeostasis is restored within 12 h. Mouse liver SIRT1 and AMP-activated protein kinase (AMPK) protein expression levels decline precipitously within 10 min and remain below detection levels for up to 12 h post-endotoxin administration. In marked contrast, the expression of HIF-1α is induced within 90 min and remains elevated for up to 12 h. The ATP recovery is delayed, and the increases in both HIF-1α expression and autophagy are prolonged in endotoxin-challenged SIRT1 liver knock-out mice. Resveratrol prevents the decline in ATP concentration and SIRT1 expression, as well as the increase in HIF-1α expression and autophagy in liver of endotoxin-challenged wild type mice but not in SIRT1 liver knock-out mice. These results provide novel insight into the state of both cellular bioenergetics and metabolic networks during the acute phase of systemic inflammation and suggest a role for SIRT1 in acute metabolic decline, as well as the restoration of metabolic homeostasis during an inflammatory challenge.
Beneficial Effects of -Derived Bioactive Compounds in the Epigenetic Program of Neurodevelopment.
Russo C, Valle M, DAngeli F, Surdo S, Giunta S, Barbera A Nutrients. 2024; 16(14).
PMID: 39064669 PMC: 11280255. DOI: 10.3390/nu16142225.
Patil R, Telang G, Aswar U, Vyas N In Silico Pharmacol. 2024; 12(1):38.
PMID: 38706886 PMC: 11065812. DOI: 10.1007/s40203-024-00211-6.
Emerging roles of SIRT1 activator, SRT2104, in disease treatment.
Chang N, Li J, Lin S, Zhang J, Zeng W, Ma G Sci Rep. 2024; 14(1):5521.
PMID: 38448466 PMC: 10917792. DOI: 10.1038/s41598-024-55923-8.
Grabowska A, Watroba M, Witkowska J, Mikulska A, Sepulveda N, Szukiewicz D Int J Mol Sci. 2023; 24(14).
PMID: 37511397 PMC: 10380505. DOI: 10.3390/ijms241411640.
Dehydrozingerone promotes healing of diabetic foot ulcers: a molecular insight.
Begum F, Manandhar S, Kumar G, Keni R, Sankhe R, Gurram P J Cell Commun Signal. 2022; 17(3):673-688.
PMID: 36280629 PMC: 10409929. DOI: 10.1007/s12079-022-00703-0.